Balentine LLC Baxter International Inc Transaction History

Balentine LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $256,686 - $339,016	-6,878 Reduced 54.49%	5,744 $216,000
Q2 2023 Aug 14, 2023	SELL	$39.98 - $47.68 $41,899 - $49,968	-1,048 Reduced 7.67%	12,622 $575,000
Q1 2023 May 11, 2023	BUY	$37.58 - $52.57 $513,718 - $718,631	13,670 New	13,670 $554,000
Q2 2022 Oct 26, 2022	SELL	$63.83 - $80.0 $165,064 - $206,880	-2,586 Reduced 37.75%	4,265 $274,000
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $272,234 - $341,200	4,265 New	4,265 $274,000
Q1 2022 Oct 26, 2022	BUY	$76.85 - $89.45 $198,734 - $231,317	2,586 Added 60.63%	6,851 $531,000
Q4 2021 Oct 26, 2022	SELL	$74.57 - $87.19 $83,891 - $98,088	-1,125 Reduced 26.38%	3,140 $270,000
Q4 2021 Feb 02, 2022	SELL	$74.57 - $87.19 $212,748 - $248,753	-2,853 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $210,465 - $238,539	2,853 New	2,853 $229,000
Q3 2020 Nov 02, 2020	SELL	$78.33 - $90.73 $115,850 - $134,189	-1,479 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $20,687 - $24,758	-263 Reduced 15.1%	1,479 $127,000
Q1 2020 May 18, 2020	BUY	$71.57 - $93.3 $119,521 - $155,811	1,670 Added 2319.44%	1,742 $141,000
Q4 2019 Sep 02, 2020	BUY	$76.7 - $88.45 $383 - $442	5 Added 7.46%	72 $6,000
Q3 2019 Nov 15, 2019	BUY	$81.4 - $89.78 $569 - $628	7 Added 11.67%	67 $6,000
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $4,406 - $4,944	60 New	60 $5,000
Q1 2018 May 16, 2018	SELL	$62.56 - $72.26 $18,893 - $21,822	-302 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$59.5 - $64.61 $17,969 - $19,512	302	302 $19,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.